Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib can help about 14,000 people with severe hair loss.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.